NAM
ANGO icon

NorthCoast Asset Management’s AngioDynamics ANGO Stock Holding History

NorthCoast Asset Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-59,587
Closed -$966K – 157
2017
Q2 		$966K Buy
+59,587
New +$942K 0.11% 130

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SAM
Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

NorthCoast Asset Management's ANGO Position: Q3 2017 in Review

NorthCoast Asset Management sold out of AngioDynamics (ANGO) in Q3 2017, closing a stake of 59,587 shares — an estimated $966K sold.

NorthCoast Asset Management first reported a position in ANGO in Q2 2017 and held it in 1 quarter. The position peaked at $966K in Q2 2017. 168 funds tracked by Wall St. Rank hold ANGO as of Q3 2017.

  • NorthCoast Asset Management reported no remaining AngioDynamics position as of Q3 2017 after selling out during the quarter.
  • NorthCoast Asset Management sold 59,587 AngioDynamics shares in Q3 2017, an estimated $966K.
  • NorthCoast Asset Management first reported a position in AngioDynamics in Q2 2017 and held it in 1 quarter.
  • NorthCoast Asset Management's AngioDynamics position peaked at $966K in Q2 2017.
  • 168 funds tracked by Wall St. Rank held AngioDynamics as of Q3 2017.

Based on NorthCoast Asset Management's 13F filing for Q3 2017, filed 9 Nov 2017.